Navigation Links
Cell Biosciences Announces First UK System Sale
Date:3/10/2009

ces is a private life sciences company focused on nanoproteomics. We develop instrumentation systems and assays for the measurement of phosphoprotein signaling and activation in extremely small biological samples. Our company's lead product is a capillary-based nanofluidic immunoassay platform that provides quantitative and reproducible data on key signaling pathways in precious biological samples, such as small tumor biopsies and stem cells. Cell Biosciences is located in Palo Alto, California.

www.cellbiosciences.com

info@cellbiosciences.com


'/>"/>
SOURCE Cell Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Regado Biosciences to Present at the 2009 Wharton Healthcare Business Conference
2. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2008 Results
3. Enlight Biosciences Expands to direct up to $52 Million to Transformational Enabling Technologies
4. New Jersey-Based Biotech Start-Up Nexomics Biosciences Gets Off the Ground
5. URMC, Lighthouse Biosciences Awarded U.S. Patent for Diagnostic Technology
6. URMC, Lighthouse Biosciences awarded US patent for diagnostic technology
7. Abbott Completes Acquisition of Ibis Biosciences, a Subsidiary of Isis
8. CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform
9. Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus
10. Alexander R. Giaquinto, Ph.D., Joins Regado Biosciences as Senior Vice President of Regulatory Affairs and Quality Assurance
11. Cell Biosciences Introduces First Protein Analysis Kits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... TX (PRWEB) , ... July 29, 2015 , ... ... comprehensive information on the therapeutic development for Atherosclerosis. Atherosclerosis is a slow, progressive ... new targets and MOAs to produce first-in-class and best-in-class products. Complete report on ...
(Date:7/29/2015)... ... 2015 , ... Topical BioMedics, Inc., announces it has partnered ... Cream designated as the nonprofit’s natural pain reliever of choice.     , 555 ... Deaths (LODD) and the high rate of pain and injuries firefighters are suffering ...
(Date:7/29/2015)... FL (PRWEB) , ... July 29, 2015 , ... ... e-cigarette shops are anticipating testing regulations imposed by the FDA for nicotine laced ... but use of electronic cigarettes have raised considerably. E-Cigarettes are particularly troublesome to ...
(Date:7/29/2015)... ... July 29, 2015 , ... San Fernando Valley skin doctor , Dr. ... time only, patients can get the complete treatment process with a 10 percent discount ... non-invasive treatment and have loose or sagging skin. , As the only non-surgical ...
(Date:7/29/2015)... ... 2015 , ... Wedding season is in full swing, which means bridal beauty prep is officially ... on the big day. Every bride wants to look and feel beautiful, but a recent ... to a recent study by the American Academy of Facial Plastic and ...
Breaking Medicine News(10 mins):Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3
... spoke on the House floor this afternoon in support ... which provides,$50 billion over five years for programs to ... remarks:, "I want to commend Chairman Howard Berman ... to come out of the Foreign Affairs Committee under,your ...
... for proposing less governance of the practice , , ... Drug Administration draft guidelines for oversight of off-label drug ... for unapproved uses, one expert contends. , The proposed ... Randall Stafford, an associate professor of medicine at the ...
... to dramatically reduce their dose of these often harsh ... Medicine in St. Louis have taken a step closer ... drug directly on tumors in rabbits using drug-coated nanoparticles. ... than used previously for this purpose markedly slowed tumor ...
... IPC,The Hospitalist Company, Inc. (Nasdaq: IPCM ), a ... has been established,as the date of its 2008 Annual ... business on April 22, 2008 will be entitled to,receive ... which will be held,at the Hilton Los Angeles, 555 ...
... Blacksburg, Va. A research team from the Virginia ... superfamily of pathogen genes involved in the infection of ... plant pathogens Phytophthora ramorum and Phytophthora sojae. The pathogen ... work in such a way as to make the ...
... 2, 2008 Henry Nicholas,president of the 150,000-member ... AFL-CIO, announced today that his 16000-plus members of,the ... of the,United Child Care Union across Pennsylvania will ... primary., "We need change," Nicholas told delegates ...
Cached Medicine News:Health News:Pelosi on Global HIV/AIDS Bill: 'There is a Moral Imperative to Combat This Epidemic' 2Health News:Pelosi on Global HIV/AIDS Bill: 'There is a Moral Imperative to Combat This Epidemic' 3Health News:Off-Label Drug Use Needs Strong Oversight 2Health News:Nano-sized technology has super-sized effect on tumors 2Health News:Nano-sized technology has super-sized effect on tumors 3Health News:IPC The Hospitalist Company Sets 2008 Annual Meeting Date 2Health News:Huge virulence gene superfamily responsible for devastating plant diseases 2
(Date:7/29/2015)... 2015 Varian Medical Systems, Inc., (NYSE: VAR ... European subsidiaries, agreed to acquire Claymount, a privately-held, ... for X-ray imaging equipment manufacturers. Varian,s subsidiary in ... in cash for Claymount. The transaction is expected to ... one of the world,s leading suppliers of high voltage ...
(Date:7/29/2015)... July 29, 2015  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... for the second quarter ended June 30, 2015. ... both HETLIOZ and Fanapt" said Mihael H. Polymeropoulos M.D., ... and life cycle management of our products set the ...   Financial Highlights , Total net ...
(Date:7/29/2015)... Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a ... medicine, today announced that it will release second quarter ... after the close of the U.S. financial markets. The ... Monday, August 10, 2015 at 4:30 p.m. Eastern / ... developments. For both "listen-only" participants and those ...
Breaking Medicine Technology:Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 2Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 3Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 4Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 2Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 3Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 4Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 5Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 6Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 7Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 8Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 9Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 10Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 11Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 12Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 13Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 14Asterias Biotherapeutics to Report Second Quarter Results on August 10, 2015 2
... PARSIPPANY, N.J., Feb. 3, 2011 Pacira Pharmaceuticals, Inc. (Nasdaq: ... announced the pricing of its initial public offering of 6,000,000 ... underwriting discounts and commissions. All of the common stock is ... trading on the NASDAQ Global Market under the symbol "PCRX" ...
... Feb. 3, 2011 Generex Biotechnology Corporation ( ... ), together with its wholly-owned immunotherapeutic vaccines subsidiary, ... that Antigen Express has received a Notice of ... to an application making augmentative pharmaceutical composition claims ...
Cached Medicine Technology:Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering 2Generex Oncology Receives New Patent for AE37 Immunotherapeutic Cancer Vaccine 2Generex Oncology Receives New Patent for AE37 Immunotherapeutic Cancer Vaccine 3
... The Accutest Infectious Mononucleosis Whole ... test used for the detection of ... (IM) in human whole blood. This ... help in the diagnosis of IM ...
... test for the visual, qualitative ... to infectious mononucleosis in human ... specimens. This test is intended ... diagnosis of infectious mononucleosis in ...
... Influenza A+B test allows for the ... A and type B antigens directly ... nasal aspirate specimens. The test is ... rapid differential diagnosis of acute influenza ...
The NOW® Flu B test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results an...
Medicine Products: